A clinicopathologic analysis revealed that tumor size, TNM stage, and metastasis were significantly improved in the MAGI2‐AS3 high‐expression group compared with the MAGI2‐AS3 low‐expression group (p <.05, Table 2). The gene discussed is PDS5B; the disease is neoplasm.